UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells

Breast cancer research and treatment, 2015-05, Vol.151 (1), p.57-73

2015

Volltextzugriff (PDF)

Arrested Developments: CDK4/6 Inhibitor Resistance and Alterations in the Tumor Immune Microenvironment

Clinical cancer research, 2019-02, Vol.25 (3), p.921-927

2019

Volltextzugriff (PDF)

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma

EMBO molecular medicine, 2019-02, Vol.11 (2), p.1-n/a

2019

Volltextzugriff (PDF)

Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase Inhibition

Journal of investigative dermatology, 2020-11, Vol.140 (11), p.2242-2252.e7

2020

Volltextzugriff (PDF)

Playing the Melanoma Endgame

Clinical cancer research, 2018-10, Vol.24 (19), p.4629-4630

2018

Volltextzugriff (PDF)

In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms

Cancer discovery, 2018-05, Vol.8 (5), p.568-581

2018

Volltextzugriff (PDF)

Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal Melanoma

Molecular cancer therapeutics, 2020-08, Vol.19 (8), p.1719-1726

2020

Volltextzugriff (PDF)

Glutamatergic signaling in cellular transformation

Pigment cell and melanoma research, 2012-05, Vol.25 (3), p.331-342

2012

Volltextzugriff (PDF)

An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in Melanoma

Cancer research (Chicago, Ill.), 2016-09, Vol.76 (18), p.5455-5466

2016

Volltextzugriff (PDF)

Frizzled with age: an opportunity for 'gerontological medicine'

Pigment cell and melanoma research, 2016-09, Vol.29 (5), p.488-489

Teh, Jessica L. F.

2016

Volltextzugriff (PDF)

Activation of CD8 + T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors

Cancer immunology research, 2020-09, Vol.8 (9), p.1114-1121

2020

Volltextzugriff (PDF)

Metabotropic glutamate receptor 1 mediates melanocyte transformation via transactivation of insulin-like growth factor 1 receptor

Pigment cell and melanoma research, 2014-07, Vol.27 (4), p.621-629

2014

Volltextzugriff (PDF)

Correction: In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms

Cancer discovery, 2018-12, Vol.8 (12), p.1654-1654

2018

Volltextzugriff (PDF)

A Preexisting Rare PIK3CA E545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 Signaling

Cancer discovery, 2018-05, Vol.8 (5), p.556-567

2018

Volltextzugriff (PDF)

Abstract A005: The aged tumor microenvironment influences tolerance to targeted therapy via NR2F1 overexpression in BRAF-mutant melanoma

Cancer research (Chicago, Ill.), 2023-01, Vol.83 (2_Supplement_1), p.A005-A005

2023

Volltextzugriff (PDF)

A pre-existing rare PIK3CAE545K subpopulation confers clinical resistance to MEK plus CDK4/6 inhibition in NRAS melanoma and is dependent on S6K1 signaling

Cancer discovery, 2018-03, Vol.8 (5), p.556-567

2018

Volltextzugriff (PDF)

The TNF Receptor Superfamily-NF-κB Axis Is Critical to Maintain Effector Regulatory T Cells in Lymphoid and Non-lymphoid Tissues

Cell reports (Cambridge), 2017-09, Vol.20 (12), p.2906-2920

2017

Volltextzugriff (PDF)

Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia

Circulation (New York, N.Y.), 2015-02, Vol.131 (8), p.730-741

2015

Volltextzugriff (PDF)

Seroreactivity to mucosa associated microbiota is associated with T cell gut‐homing in functional dyspepsia patients

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells

Cell reports. Medicine, 2023-04, Vol.4 (4), p.101017-101017, Article 101017

2023

Volltextzugriff (PDF)

Targeting PHGDH upregulation reduces glutathione levels and re-sensitizes resistant NRAS mutant melanoma to MEK inhibition

Journal of investigative dermatology, 2020-05, Vol.140 (11), p.2242-2252.e7

2020

Volltextzugriff (PDF)

Sa533 NOVEL CHARACTERIZATION OF THE SECRETOMES OF CROHN'S DISEASE MUCOSA-ASSOCIATED MICROBIOTA, AND THEIR MODULATION OF INFLAMMATION THROUGH NF-κB SIGNALLING. THE ENIGMA STUDY

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-538-S-539

2021

Volltextzugriff (PDF)

Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer

Brachytherapy, 2024-09, Vol.23 (5), p.559-568

2024

Volltextzugriff (PDF)

4 CROHN'S DISEASE PATHOBIONT ENTEROBACTERIACEAE GROWTH IS MODULATED BY FOOD ADDITIVES AND OXYGEN AVAILABILITY: FACTORS IN PATHOPHYSIOLOGY AND RECURRENCE. THE ENIGMA STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-2-S-2

2020

Volltextzugriff (PDF)

Mesenchymal Lineage Stem Cells Have Pronounced Anti‐Inflammatory Effects in the Twitcher Mouse Model of Krabbe's Disease

Stem cells (Dayton, Ohio), 2011-01, Vol.29 (1), p.67-77

2011

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells

Arrested Developments: CDK4/6 Inhibitor Resistance and Alterations in the Tumor Immune Microenvironment

Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma

Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase Inhibition

Playing the Melanoma Endgame

In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms

Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal Melanoma

Glutamatergic signaling in cellular transformation

An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in Melanoma

Frizzled with age: an opportunity for 'gerontological medicine'

Activation of CD8 + T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors

Metabotropic glutamate receptor 1 mediates melanocyte transformation via transactivation of insulin-like growth factor 1 receptor

Correction: In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance Mechanisms

A Preexisting Rare PIK3CA E545K Subpopulation Confers Clinical Resistance to MEK plus CDK4/6 Inhibition in NRAS Melanoma and Is Dependent on S6K1 Signaling

Abstract A005: The aged tumor microenvironment influences tolerance to targeted therapy via NR2F1 overexpression in BRAF-mutant melanoma

A pre-existing rare PIK3CAE545K subpopulation confers clinical resistance to MEK plus CDK4/6 inhibition in NRAS melanoma and is dependent on S6K1 signaling

The TNF Receptor Superfamily-NF-κB Axis Is Critical to Maintain Effector Regulatory T Cells in Lymphoid and Non-lymphoid Tissues

Elevated placental adenosine signaling contributes to the pathogenesis of preeclampsia

Seroreactivity to mucosa associated microbiota is associated with T cell gut‐homing in functional dyspepsia patients

Robust SARS-CoV-2 T cell responses with common TCRαβ motifs toward COVID-19 vaccines in patients with hematological malignancy impacting B cells

Targeting PHGDH upregulation reduces glutathione levels and re-sensitizes resistant NRAS mutant melanoma to MEK inhibition

Sa533 NOVEL CHARACTERIZATION OF THE SECRETOMES OF CROHN'S DISEASE MUCOSA-ASSOCIATED MICROBIOTA, AND THEIR MODULATION OF INFLAMMATION THROUGH NF-κB SIGNALLING. THE ENIGMA STUDY

Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer

4 CROHN'S DISEASE PATHOBIONT ENTEROBACTERIACEAE GROWTH IS MODULATED BY FOOD ADDITIVES AND OXYGEN AVAILABILITY: FACTORS IN PATHOPHYSIOLOGY AND RECURRENCE. THE ENIGMA STUDY

Mesenchymal Lineage Stem Cells Have Pronounced Anti‐Inflammatory Effects in the Twitcher Mouse Model of Krabbe's Disease

Suchergebnisse filtern